EDGAR Filing Documents for 0001842952-22-000100

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001842952-22-000100

Filing Date

2022-11-09

Accepted

2022-11-09 16:26:33

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	prosupp10-qnov92022.htm	424B3	654840
2		image_0.jpg	GRAPHIC	47702
	Complete submission text file	0001842952-22-000100.txt		717485

Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103

Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416

Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-261599 | Film No.: 221373073
SIC: 2834 Pharmaceutical Preparations